Webinar recorded on June 6, 2019.
Under the federal Controlled Substances Act, marijuana is currently categorized as a Schedule 1 drug – that is, a drug with high potential for abuse with no currently accepted medical use in treatment in the U.S. Despite the growing number of states that legalize marijuana for medicinal purposes or recreational use, it remains a federal offense to cultivate, manufacture, distribute, sell, purchase, possess, or use marijuana.
Drawing from the experience and slow progression of federal tobacco regulation, this webinar examines several legal and policy implications if the federal government were to remove marijuana and tetrahydrocannabinols from Schedule 1 classification. Presenters will flag a range of potential issues to consider were this scenario to occur — including the federal government’s revised regulatory oversight role; factors influencing the persistent illegal market; state and local control in many facets of marijuana regulation; and the likely development of a major consolidated marijuana industry, similar to the tobacco industry.
Rachel Callanan, Public Health Law Center
Kerry Cork, Public Health Law Center
Hudson Kingston, Public Health Law Center